Literature DB >> 7689392

Characterization of the binding of [3H]-L-NG-nitro-arginine in rat brain.

A D Michel1, R K Phul, T L Stewart, P P Humphrey.   

Abstract

In the present study tritiated L-NG-nitro-arginine (L-NOARG) has been shown to label specific binding sites in rat brain cytosol. We conclude that this ligand is directly labelling nitric oxide synthase (NOS). This conclusion is based on our observations (i) that binding was stereoselectively inhibited by L-arginine, in preference to D-arginine, and (ii) that a number of different NOS inhibitors were able to displace [3H]-L-NOARG binding at similar concentrations to those required to inhibit the activity of rat brain cytosol NOS in functional studies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689392      PMCID: PMC2175700          DOI: 10.1111/j.1476-5381.1993.tb13566.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  6 in total

1.  Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase.

Authors:  D S Bredt; P M Hwang; C E Glatt; C Lowenstein; R R Reed; S H Snyder
Journal:  Nature       Date:  1991-06-27       Impact factor: 49.962

2.  Nitric oxide synthase: irreversible inhibition by L-NG-nitroarginine in brain in vitro and in vivo.

Authors:  M A Dwyer; D S Bredt; S H Snyder
Journal:  Biochem Biophys Res Commun       Date:  1991-05-15       Impact factor: 3.575

3.  7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure.

Authors:  P K Moore; R C Babbedge; P Wallace; Z A Gaffen; S L Hart
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

4.  Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line.

Authors:  C R Lyons; G J Orloff; J M Cunningham
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

5.  Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform.

Authors:  S Lamas; P A Marsden; G K Li; P Tempst; T Michel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

6.  L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.

Authors:  P K Moore; O A al-Swayeh; N W Chong; R A Evans; A Gibson
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

  6 in total
  4 in total

1.  Regional distribution of binding sites for the nitric oxide synthase inhibitor L-[3H]nitroarginine in rat brain.

Authors:  V L Rao; R F Butterworth
Journal:  Neurochem Res       Date:  1996-03       Impact factor: 3.996

Review 2.  Neuronal nitric oxide synthase and Hepatic Encephalopathy.

Authors:  V L Rao; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-09       Impact factor: 3.584

3.  Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth-retarded and pre-eclamptic pregnancies.

Authors:  R A Rutherford; A McCarthy; M H Sullivan; M G Elder; J M Polak; J Wharton
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

4.  Effect of 7-nitro indazole on neurotransmission in the rat vas deferens: mechanisms unrelated to inhibition of nitric oxide synthase.

Authors:  H S Allawi; P Wallace; A Pitcher; Z Gaffen; P A Bland-Ward; P K Moore
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.